Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia

Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia

Ventilator-associated pneumonia is one of the most common infections in Intensive Care Units (ICU). It is frequently caused by multidrug-resistant pathogens (including carbapenems) and is an important health issue. It may result in severe clinical consequences, with higher healthcare utilization and...

Full description

Saved in:
Bibliographic Details
Main Authors: Jessica Matuoka, Daniela Vianna Pachito, Filipe Piastrelli, Lorena Cristina Correa Fehlberg, Haliton Alves de Oliveira Junior
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Pneumonia, Ventilator-associated
Ceftazidime-avibactam
Polymyxin B
Cost-effectiveness analysis
Critical care
Carbapenem-resistant
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867025000467
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items